NCR Graphs - All Cancers

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 200units	200units	Injectable lyophilised powder for solution	25,175,058 L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 50units	50units	Injectable lyophilised powder for solution	8,904,323 L.L
L01BC05	GEMTABINE 1000	G	Gemcitabine HCl - 1,000mg	1,000mg	Injectable lyophilised powder for solution	4,882,628 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
A16AB02	CEREZYME	B	Imiglucerase - 400IU	400IU	Injectable lyophilised powder for solution	128,412,818 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,197,802 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	5,915,595 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,956,454 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
J05AB16	FLEXIVIR	G	Remdesivir - 50mg	50mg	Injectable lyophilised powder for solution	4,837,833 L.L
L01XX02	ERWINASE	BioTech	Erwinia L-asparaginase - 10,000IU	10,000IU	Injectable lyophilised powder for solution	444,434,845 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate) - 15U	15U	Injectable lyophilised powder for solution	2,109,833 L.L
J01AA12	TYGACIL	B	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	25,356,524 L.L
J01AA12	TAGIX	G	Tigecycline - 50mg	50mg	Injectable lyophilised powder for solution	2,436,386 L.L
J07AH08	NIMENRIX	B	Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml		Injectable lyophilised powder for solution+diluent	4,483,059 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,561,486 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	27,354,631 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	47,481,122 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	23,067,288 L.L
J07BD52	PRIORIX	B	Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50		Injectable lyophilised powder for solution+diluent	1,142,266 L.L

NCR graphs - Incidence rates by year